72.19.Z - Other research and experimental development on natural sciences and engineering
38.22.Z - Hazardous waste processing and neutralizing
38.32.Z - Recovery of sorted materials
68.20.Z - Rental and operating of own or leased real estate
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | 0 | 3,3 | -55 | -1781,8 |
Gross profit (loss) | 0 | 3,3 | -55 | -1782,3 |
EBITDA | 0 | 3,3 | -55 | -1781,4 |
Short time liabilities | 0 | 1,7 | 107,9 | 6298,7 |
Other operating costs | 0 | 0 | 0 | 750 |
Equity capital | 5 | 7,9 | -47,1 | -694,3 |
Operating profit (EBIT) | 0 | 3,3 | -55 | -1781,4 |
Assets | 5 | 9,6 | 60,8 | 532,7 |
Net profit (loss) | 0 | 2,9 | -55 | -1982 |
Cash | 0 | 5,7 | 2,4 | -58,1 |
Liabilities and provisions for liabilities | 0 | 1,7 | 107,9 | 6298,7 |
Net income from sale | 0 | 18,7 | 109,6 | 486,1 |
Working assets | 0 | 9,6 | 60,8 | 532,7 |
Other income costs | 0 | 0 | 0 | 18,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0 | 36,9 | 116,8 | 79,9 |
Equity capital to total assets | 100 | 82,5 | -77,4 | -159,9 |
Gross profit margin | 17,5 | -50,2 | -67,7 | |
EBITDA Margin | 17,5 | -50,2 | -67,7 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 33 | 359 | 326 |
Current financial liquidity indicator | 5.699113845825195 | 0.5635557770729065 | -5,1 | |
Net dept to EBITDA | -1.7349134683609009 | 0.04319227114319801 | 1,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane